Résultats de la recherche - 5 results
Clinical Evolution and Disease Burden in Belgian Cystic Fibrosis Patients: effect of Newborn Screening?
1 year of age were better in NBS patients (median =-0.13, IQR-0.99 – 0.50) compared to non- NBS patients (MI median =-0.56, IQR =-01.53 – 0.02, non- NBS median =-0.54, IQR =-1.02 – 0.12, p = 0.03377). ...
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
lung-transplanted (28.6; 95% CI: 22.7-35.5) non-lung-transplanted pwCF (16.6; 95% CI: 15.4-17.8) (p≤0.001). SARS-CoV-2 infection caused symptomatic illness in 75.7%. Factors associated with symptomatic SARS-CoV-2 ...
COVID-19 vaccine prioritisation for people with cystic fibrosis.
Vicente R F da Silva; Anne L Stephenson; Stephanie Y Cheng; Joel Melo; Harriet Corvol; Pierre-Régis Burgel; Nährlich, Lutz; Edward McKone; Colombo, Carla; Marco Salvatore; Rita Padoan; Olzhas Abdrakhmanov; ...
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
Nataliya; Bruce C Marshall; Edward McKone; Middleton, Peter G; Pedro Mondejar-Lopez; Dolores M Pastor-Vivero; Rita Padoan; Samar Rizvi; Rasa Ruseckaite; Marco Salvatore; Anne Stephenson; Filho, Luiz Vicente ...
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
versions: DOI: https://doi.org/10.1016/j.jcf.2020.04.012 File: Version: Published Full text access: Public Access Full text language: English Category: A1 FOS Classification: 3.02 Clinical medicine ...